Skip to main content
. 2019 Dec;11(12):5210–5217. doi: 10.21037/jtd.2019.12.11

Table 2. QFT-Plus response among different groups.

Variable Active TB (n=33) LTBI (n=30) HC (n=27)
Total AFB Cx(+) (n=16) AFB Cx(−) (n=17)
QFT-GIT
   TB+ 31 (93.9) 15 (93.8) 16 (94.1) 30 (100.0) 0 (0.0)
QFT-Plus
   TB1+ or TB2+ 31 (93.9) 15 (93.8) 16 (94.1) 26 (86.7) 2 (7.4)
   TB1+ 29 (87.9) 13 (81.3) 16 (94.1) 26 (86.7) 0 (0.0)
   TB2+ 31 (93.9) 15 (93.8) 16 (94.1) 24 (80.0) 2 (7.4)
   Only TB1+ 0 (0.0) 0 (0.0) 0 (0.0) 2 (6.7) 0 (0.0)
   Only TB2+ 2 (6.1) 2 (12.5) 0 (0.0) 0 (0.0) 2 (7.4)
   TB1 and TB2 29 (87.9) 13 (81.3) 16 (94.1) 24 (80.0) 0 (0.0)

The numbers in brackets represent percentages in each category. AFB, acid fast bacilli; Cx, culture; n, number; LTBI, latent tuberculosis infection; HC, healthy control; QFT-GIT, QuantiFERON-TB Gold In-Tube; QFT Plus, QuantiFERON-TB Gold Plus.